The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First assessment of the stool mycobiome in patients (pts) with metastatic renal cell carcinoma (mRCC) receiving targeted therapy (TT) or immunotherapy (IO).
 
Nazli Dizman
No Relationships to Disclose
 
Joann Hsu
No Relationships to Disclose
 
John D Gillece
No Relationships to Disclose
 
Megan Folkerts
Employment - TGen
 
Lauren J Reining
Employment - TGEN
 
Paulo Gustavo Bergerot
No Relationships to Disclose
 
Luis A Meza
No Relationships to Disclose
 
Zeynep Busra Zengin
No Relationships to Disclose
 
Ramya Muddasani
No Relationships to Disclose
 
Neal Chawla
No Relationships to Disclose
 
Misagh Karimi
Honoraria - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Seattle Genetics/Astellas
Consulting or Advisory Role - GlaxoSmithKline
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jeffrey M. Trent
Employment - TGen
Leadership - TGen
 
Sarah K Highlander
No Relationships to Disclose
 
Sumanta K. Pal
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer